• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微生物代谢产物丁酸盐通过调节细胞毒性 CD8 T 细胞的 T 细胞受体信号来增强抗 PD-1 抗肿瘤疗效。

Microbial metabolite butyrate promotes anti-PD-1 antitumor efficacy by modulating T cell receptor signaling of cytotoxic CD8 T cell.

机构信息

Department of Oncology, First Affiliated Hospital, Jinan University, Guangzhou, China.

Department of Geriatrics, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, China.

出版信息

Gut Microbes. 2023 Dec;15(2):2249143. doi: 10.1080/19490976.2023.2249143.

DOI:10.1080/19490976.2023.2249143
PMID:37635362
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10464552/
Abstract

Recent studies have demonstrated that the antitumor immunity of immune cells can be modulated by gut microbiota and their metabolites. However, the underlying mechanisms remain unclear. Here, we showed that the serum butyric acid level is positively correlated with the expression of programmed cell death-1 (PD-1) on circulating CD8 and Vγ9 Vδ2 (Vδ2) T cells in patients with non-small cell lung cancer (NSCLC). Responder NSCLC patients exhibited higher levels of serum acetic acid, propionic acid, and butyric acid than non-responders. Depletion of the gut microbiota reduces butyrate levels in both feces and serum in tumor-bearing mice. Mechanistically, butyrate increased histone 3 lysine 27 acetylation (H3K27ac) at the promoter region of and in human CD8 T cells, thereby promoting the expression of PD-1/CD28 and enhancing the efficacy of anti-PD-1 therapy. Butyrate supplementation promotes the expression of antitumor cytokines in cytotoxic CD8 T cells by modulating the T-cell receptor (TCR) signaling pathway. Collectively, our findings reveal that the metabolite butyrate of the gut microbiota facilitates the efficacy of anti-PD-1 immunotherapy by modulating TCR signaling of cytotoxic CD8 T cells, and is a highly promising therapeutic biomarker for enhancing antitumor immunity.

摘要

最近的研究表明,免疫细胞的抗肿瘤免疫可以被肠道微生物群及其代谢物调节。然而,其潜在机制尚不清楚。在这里,我们表明,非小细胞肺癌(NSCLC)患者的循环 CD8 和 Vγ9Vδ2(Vδ2)T 细胞中程序性细胞死亡蛋白-1(PD-1)的表达与血清丁酸水平呈正相关。应答者 NSCLC 患者的血清乙酸、丙酸和丁酸水平高于无应答者。肠道微生物群的耗竭会降低荷瘤小鼠粪便和血清中的丁酸盐水平。在机制上,丁酸盐增加了人 CD8 T 细胞中 和 启动子区域的组蛋白 3 赖氨酸 27 乙酰化(H3K27ac),从而促进 PD-1/CD28 的表达,并增强抗 PD-1 治疗的疗效。丁酸盐通过调节 T 细胞受体(TCR)信号通路促进细胞毒性 CD8 T 细胞中抗肿瘤细胞因子的表达。总之,我们的研究结果表明,肠道微生物群的代谢物丁酸通过调节细胞毒性 CD8 T 细胞的 TCR 信号来促进抗 PD-1 免疫疗法的疗效,是增强抗肿瘤免疫的极具前景的治疗生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb33/10464552/2be990ab9ed9/KGMI_A_2249143_F0006_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb33/10464552/4621b58953b9/KGMI_A_2249143_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb33/10464552/d3115895c2e8/KGMI_A_2249143_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb33/10464552/0614f3931d0e/KGMI_A_2249143_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb33/10464552/0f36353506d8/KGMI_A_2249143_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb33/10464552/f475a5395a49/KGMI_A_2249143_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb33/10464552/2be990ab9ed9/KGMI_A_2249143_F0006_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb33/10464552/4621b58953b9/KGMI_A_2249143_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb33/10464552/d3115895c2e8/KGMI_A_2249143_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb33/10464552/0614f3931d0e/KGMI_A_2249143_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb33/10464552/0f36353506d8/KGMI_A_2249143_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb33/10464552/f475a5395a49/KGMI_A_2249143_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb33/10464552/2be990ab9ed9/KGMI_A_2249143_F0006_OC.jpg

相似文献

1
Microbial metabolite butyrate promotes anti-PD-1 antitumor efficacy by modulating T cell receptor signaling of cytotoxic CD8 T cell.微生物代谢产物丁酸盐通过调节细胞毒性 CD8 T 细胞的 T 细胞受体信号来增强抗 PD-1 抗肿瘤疗效。
Gut Microbes. 2023 Dec;15(2):2249143. doi: 10.1080/19490976.2023.2249143.
2
1α,25(OH)D reverses exhaustion and enhances antitumor immunity of human cytotoxic T cells.1α,25-二羟基维生素D可逆转人细胞毒性T细胞耗竭并增强其抗肿瘤免疫。
J Immunother Cancer. 2022 Mar;10(3). doi: 10.1136/jitc-2021-003477.
3
Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer.果胶补充剂显著增强了用来自结直肠癌患者的肠道微生物群人源化的荷瘤小鼠的抗PD-1疗效。
Theranostics. 2021 Feb 19;11(9):4155-4170. doi: 10.7150/thno.54476. eCollection 2021.
4
Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8 T cell immunity.肠道微生物代谢物通过调节细胞毒性 CD8 T 细胞免疫来促进癌症治疗疗效。
Cell Metab. 2021 May 4;33(5):988-1000.e7. doi: 10.1016/j.cmet.2021.03.002. Epub 2021 Mar 23.
5
Gut microbiota modulate CD8 T cell immunity in gastric cancer through Butyrate/GPR109A/HOPX.肠道微生物群通过丁酸/GPR109A/HOPX 调节胃癌中的 CD8 T 细胞免疫。
Gut Microbes. 2024 Jan-Dec;16(1):2307542. doi: 10.1080/19490976.2024.2307542. Epub 2024 Feb 6.
6
N-methyladenosine-modified circIGF2BP3 inhibits CD8 T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer.N6-甲基腺苷修饰的环状 IGF2BP3 通过促进非小细胞肺癌中 PD-L1 的去泛素化来抑制 CD8 T 细胞反应,从而促进肿瘤免疫逃逸。
Mol Cancer. 2021 Aug 20;20(1):105. doi: 10.1186/s12943-021-01398-4.
7
TCR Repertoire Diversity of Peripheral PD-1CD8 T Cells Predicts Clinical Outcomes after Immunotherapy in Patients with Non-Small Cell Lung Cancer.外周 PD-1CD8 T 细胞 TCR repertoire 多样性预测非小细胞肺癌患者免疫治疗后的临床结局。
Cancer Immunol Res. 2020 Jan;8(1):146-154. doi: 10.1158/2326-6066.CIR-19-0398. Epub 2019 Nov 12.
8
PD-1 blockade-unresponsive human tumor-infiltrating CD8 T cells are marked by loss of CD28 expression and rescued by IL-15.PD-1 阻断无应答的人类肿瘤浸润性 CD8 T 细胞表现为 CD28 表达缺失,并可通过 IL-15 挽救。
Cell Mol Immunol. 2021 Feb;18(2):385-397. doi: 10.1038/s41423-020-0427-6. Epub 2020 Apr 24.
9
Tetracyclines enhance antitumor T-cell immunity via the Zap70 signaling pathway.四环素通过 Zap70 信号通路增强抗肿瘤 T 细胞免疫。
J Immunother Cancer. 2024 Apr 15;12(4):e008334. doi: 10.1136/jitc-2023-008334.
10
Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.基质 PD-L1 阳性调节性 T 细胞和 PD-1 阳性 CD8 阳性 T 细胞定义了不同亚组非小细胞肺癌对 PD-1/PD-L1 阻断免疫治疗的反应。
J Thorac Oncol. 2018 Apr;13(4):521-532. doi: 10.1016/j.jtho.2017.11.132. Epub 2017 Dec 18.

引用本文的文献

1
Effect of Nematodes-Bacteria Complex Metabolites on Cancer and Tumor Progression.线虫-细菌复合代谢产物对癌症和肿瘤进展的影响
Biomolecules. 2025 Aug 14;15(8):1165. doi: 10.3390/biom15081165.
2
Lipid metabolic reprogramming in colorectal cancer: mechanisms and therapeutic strategies.结直肠癌中的脂质代谢重编程:机制与治疗策略
Front Immunol. 2025 Jul 11;16:1603032. doi: 10.3389/fimmu.2025.1603032. eCollection 2025.
3
Enhancing outcomes in medically inoperable early-stage NSCLC with gut-targeted antibiotics and stereotactic body radiotherapy: results from a randomized pilot study.

本文引用的文献

1
The role of the sex hormone-gut microbiome axis in tumor immunotherapy.性激素-肠道微生物群轴在肿瘤免疫治疗中的作用。
Gut Microbes. 2023 Jan-Dec;15(1):2185035. doi: 10.1080/19490976.2023.2185035.
2
Bodywide ecological interventions on cancer.全身性生态干预癌症。
Nat Med. 2023 Jan;29(1):59-74. doi: 10.1038/s41591-022-02193-4. Epub 2023 Jan 19.
3
γδ T cells are effectors of immunotherapy in cancers with HLA class I defects.γδ T 细胞是 HLA I 类缺陷癌症免疫治疗的效应细胞。
肠道靶向抗生素与立体定向体部放疗改善医学上无法手术的早期非小细胞肺癌的疗效:一项随机试验研究结果
J Immunother Cancer. 2025 Jul 10;13(7):e011356. doi: 10.1136/jitc-2024-011356.
4
The microbial metabolite butyrate enhances the effector and memory functions of murine CD8+ T cells and improves anti-tumor activity.微生物代谢产物丁酸可增强小鼠CD8+T细胞的效应和记忆功能,并提高抗肿瘤活性。
Front Med (Lausanne). 2025 Jun 24;12:1577906. doi: 10.3389/fmed.2025.1577906. eCollection 2025.
5
Identification and validation of parthanatos-related genes in end-stage renal disease.终末期肾病中PARP1依赖性细胞坏死相关基因的鉴定与验证
Ren Fail. 2025 Dec;47(1):2519834. doi: 10.1080/0886022X.2025.2519834. Epub 2025 Jul 6.
6
Faecalibacterium prausnitzii promotes anti-PD-L1 efficacy in natural killer/T-cell lymphoma by enhancing antitumor immunity.普拉梭菌通过增强抗肿瘤免疫力促进自然杀伤/T细胞淋巴瘤的抗PD-L1疗效。
BMC Med. 2025 Jul 1;23(1):387. doi: 10.1186/s12916-025-04230-8.
7
Gut microbial metabolite butyrate suppresses hepatocellular carcinoma growth via CXCL11-dependent enhancement of natural killer cell infiltration.肠道微生物代谢产物丁酸通过CXCL11依赖性增强自然杀伤细胞浸润来抑制肝细胞癌生长。
Gut Microbes. 2025 Dec;17(1):2519706. doi: 10.1080/19490976.2025.2519706. Epub 2025 Jun 27.
8
Unraveling the Role of the Microbiota in Cancer Immunotherapy: A New Frontier.解析微生物群在癌症免疫治疗中的作用:一个新的前沿领域。
Research (Wash D C). 2025 Jun 24;8:0744. doi: 10.34133/research.0744. eCollection 2025.
9
Microbial Metabolite Effects on Vasculogenic Mimicry in Metastatic Cancers.微生物代谢产物对转移性癌症中血管生成拟态的影响
Cells. 2025 May 30;14(11):811. doi: 10.3390/cells14110811.
10
Microbiota-derived metabolites in tumorigenesis: mechanistic insights and therapeutic implications.微生物群衍生代谢产物在肿瘤发生中的作用:机制洞察与治疗意义
Front Pharmacol. 2025 May 15;16:1598009. doi: 10.3389/fphar.2025.1598009. eCollection 2025.
Nature. 2023 Jan;613(7945):743-750. doi: 10.1038/s41586-022-05593-1. Epub 2023 Jan 11.
4
Enhancing the Antitumor Immunity of T Cells by Engineering the Lipid-Regulatory Site of the TCR/CD3 Complex.通过工程化 TCR/CD3 复合物的脂质调节位点来增强 T 细胞的抗肿瘤免疫。
Cancer Immunol Res. 2023 Jan 3;11(1):93-108. doi: 10.1158/2326-6066.CIR-21-1118.
5
Clinical implications of T cell exhaustion for cancer immunotherapy.T 细胞耗竭对癌症免疫治疗的临床意义。
Nat Rev Clin Oncol. 2022 Dec;19(12):775-790. doi: 10.1038/s41571-022-00689-z. Epub 2022 Oct 10.
6
Microbial short-chain fatty acids: a strategy to tune adoptive T cell therapy.微生物短链脂肪酸:一种调节过继性 T 细胞疗法的策略。
J Immunother Cancer. 2022 Jul;10(7). doi: 10.1136/jitc-2021-004147.
7
Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunities.肿瘤部位的适应性免疫抵抗:机制与治疗机会。
Nat Rev Drug Discov. 2022 Jul;21(7):529-540. doi: 10.1038/s41573-022-00493-5. Epub 2022 Jun 14.
8
Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies.肠道微生物群影响免疫治疗反应:机制和治疗策略。
J Hematol Oncol. 2022 Apr 29;15(1):47. doi: 10.1186/s13045-022-01273-9.
9
1α,25(OH)D reverses exhaustion and enhances antitumor immunity of human cytotoxic T cells.1α,25-二羟基维生素D可逆转人细胞毒性T细胞耗竭并增强其抗肿瘤免疫。
J Immunother Cancer. 2022 Mar;10(3). doi: 10.1136/jitc-2021-003477.
10
induced antitumor immunity and synergized with anti-programmed cell death 1 to reduce tumor burden in mice.诱导抗肿瘤免疫,并与抗程序性细胞死亡 1 协同作用,减少小鼠的肿瘤负担。
Gut Microbes. 2022 Jan-Dec;14(1):2046246. doi: 10.1080/19490976.2022.2046246.